Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 232 (7%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3280 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ACEBUTOLOL | 100MG | TABLET | Resolved | 2018-12-05 | 2019-02-01 | 68706 |
| APO-ACEBUTOLOL | 100MG | TABLET | Resolved | 2018-12-12 | 2019-02-01 | 69293 |
| APO-ACEBUTOLOL | 400MG | TABLET | Resolved | 2018-12-18 | 2019-02-01 | 69911 |
| APO-ACEBUTOLOL | 400MG | TABLET | Resolved | 2021-11-12 | 2021-11-19 | 149152 |
| APO-ACEBUTOLOL | 200MG | TABLET | Resolved | 2022-06-17 | 2022-09-23 | 162899 |
| APO-ACEBUTOLOL | 400MG | TABLET | Resolved | 2022-07-22 | 2022-09-23 | 165314 |
| APO-ACEBUTOLOL | 100MG | TABLET | Resolved | 2022-08-12 | 2022-09-23 | 166598 |
| APO-ACEBUTOLOL | 200MG | TABLET | Resolved | 2023-02-23 | 2023-03-16 | 185448 |
| APO-ACEBUTOLOL | 100MG | TABLET | Resolved | 2023-10-20 | 2023-12-15 | 207725 |
| APO-ACEBUTOLOL | 200MG | TABLET | Resolved | 2023-11-17 | 2023-12-15 | 210707 |
| APO-ACEBUTOLOL | 400MG | TABLET | Resolved | 2024-05-31 | 2024-09-06 | 229410 |
| APO-ACEBUTOLOL | 200MG | TABLET | Resolved | 2024-08-22 | 2024-09-06 | 235708 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2021-09-24 | 2021-09-28 | 146151 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2022-05-13 | 2022-07-11 | 160601 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2022-08-09 | 2022-10-20 | 166399 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2022-09-23 | 2022-10-21 | 170106 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2024-08-01 | 2024-08-16 | 234283 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2024-10-18 | 2025-01-03 | 240635 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2025-07-10 | 2025-11-07 | 262446 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2025-08-14 | 2025-11-21 | 265281 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| APO-PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |